Redhill Biopharma
RDHL
#10406
Rank
A$8.32 M
Marketcap
A$1.63
Share price
-0.87%
Change (1 day)
-82.98%
Change (1 year)

Market capitalization of Redhill Biopharma (RDHL)

Market cap: A$8.32 Million

As of February 2026 Redhill Biopharma has a market cap of A$8.32 Million. This makes Redhill Biopharma the world's 10406th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Redhill Biopharma from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026A$8.32 M-3.91%
2025A$8.66 M-39.08%
2024A$14.22 M-66.26%
2023A$42.16 M124.22%
2022A$18.8 M-89.92%
2021A$0.18 B-52.92%
2020A$0.39 B29.54%
2019A$0.30 B36.82%
2018A$0.22 B59.57%
2017A$0.14 B-43.42%
2016A$0.24 B10.14%
2015A$0.22 B57%
2014A$0.14 B68.02%
2013A$85.19 M

End of Day market cap according to different sources

On Feb 2nd, 2026 the market cap of Redhill Biopharma was reported to be:

A$8.4 Million
by Nasdaq info icon info icon
A$8.4 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
A$164.21 B 1,971,786.02%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$415.64 B 4,990,804.64%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$153.52 B 1,843,349.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$59.42 B 713,422.27%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
A$2.30 B 27,607.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel